Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec

This study has been completed.
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance Identifier:
First received: November 3, 2005
Last updated: September 18, 2011
Last verified: December 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2006
  Primary Completion Date: April 2005 (Final data collection date for primary outcome measure)